Medpace Holdings Inc
Fechado
SetorSaúde
458.38 0.52
Visão Geral
Variação de preço das ações
24h
Mín
455.98
Máximo
460.92
Rendimento | -11M 124M |
|---|---|
Vendas | -1.8M 707M |
P/E Médio do Setor | 29.031 49.712 |
EPS | 4.28 |
Margem de lucro | 17.53 |
Funcionários | 6,300 |
EBITDA | -9.5M 154M |
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | -1.73% downside |
Próximos Ganhos | 22 de jul. de 2026 |
|---|
Capitalização de Mercado | -1.9B 13B |
|---|---|
Abertura anterior | 457.86 |
Fecho anterior | 458.38 |
Sentimento de Notícias
By Acuity
26%
74%
54 / 342 Ranking em Healthcare
Medpace Holdings Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.